logo

For the Inventor, By the Inventor

Bothell, WA, United States of America

Darwin Discovery Limited

Calculating rank
USPTO Granted Patents = 90

% Expired Patents = 25.6



Forward Citations = 1,098

Loading Chart...
Loading Chart...

70 inventors (with patents filed for the assignee):

goldMedal John Gary Montana (39 out of 68 patents)

silverMedal Andrew Douglas Baxter (30 out of 44 patents)

bronzeMedal David Alan Owen (24 out of 28 patents)

4.  Hazel Joan Dyke (20 out of 30 patents)

5.  Robert John Watson (17 out of 20 patents)

6.  Mary E Brunkow (13 out of 23 patents)

7.  Andrew Sharpe (8 out of 30 patents)

8.  David J Galas (7 out of 18 patents)

9.  Bryan W Paeper (7 out of 13 patents)

10.  Verity Margaret Sabin (7 out of 11 patents)

11.  Jeffrey Van Ness (7 out of 35 patents)

12.  Duncan Robert Hannah (7 out of 7 patents)

13.  Brian Robert Kovacevich (7 out of 68 patents)

14.  John Thomas Mulligan (7 out of 32 patents)

15.  Fred Ramsdell (6 out of 11 patents)


Core Competencies:
Bone Mineralization
Hydroxamic Acid Derivatives
MMP Inhibitors
Peptidyl Compounds
Levobupivacaine
Heterocyclic Compounds
Analgesic Agents
Therapeutic Uses
Gene Identification
Biological Compositions
Carboxylic Acid Derivatives
Drug Formulations

90 patents:

1. 7994299 - Compositions and methods for increasing bone mineralization (2011-08-09),
2. 7977312 - Compositions and methods for increasing bone mineralization (2011-07-12),
3. 7758858 - Antibodies associated with alterations in bone density (2010-07-20),
4. 7192583 - Methods for modulating bone mineralization (2007-03-20),
5. 6933306 - Hydroxamic and carboxylic acid derivatives (2005-08-23),
6. 6884618 - Identification of the gene causing the mouse scurfy phenotype and its human ortholog (2005-04-26),
7. 6818622 - Selective MMP inhibitors having reduced side-effects (2004-11-16),
8. 6809100 - Hydroxamic acid derivatives (2004-10-26),
9. 6803453 - Antibodies associated with alterations in bone density (2004-10-12),
10. 6794145 - Identification of the gene causing the mouse scurfy phenotype and its human ortholog (2004-09-21),
11. 6787536 - Hydroxamic acid derivatives (2004-09-07),
12. 6734189 - Hydroxamic and carboxylic acid derivatives (2004-05-11),
13. 6706719 - Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity (2004-03-16),
14. 6683171 - Identification of the gene causing the mouse scurfy phenotype and its human ortholog (2004-01-27),
15. 6683160 - Antibodies specific for Fkhsf gene products (2004-01-27),
Company Overview
Darwin Discovery Limited, based in Bothell, WA, specializes in innovative solutions for bone mineralization. The company focuses on developing advanced therapeutic agents, including hydroxamic acid derivatives and MMP inhibitors, aimed at enhancing bone health and addressing related disorders. Their research encompasses a range of compounds, such as peptidyl and heterocyclic compounds, with applications in analgesics and other therapeutic uses, positioning them at the forefront of medical advancements in bone-related therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

90 Patents

#5 in Bothell, WA

#73 in Washington

#4,157 in US

#8,538 in the World

Bothell, WA (US)
Bothell, WA, United States of America

Darwin Discovery Limited

Forward Citations = 1,098

70 inventors:

goldMedal John Gary Montana (39 out of 68 patents)

silverMedal Andrew Douglas Baxter (30 out of 44 patents)

bronzeMedal David Alan Owen (24 out of 28 patents)

4.  Hazel Joan Dyke (20 out of 30 patents)

5.  Robert John Watson (17 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Darwin Discovery Limited. Retrieved from https://idiyas.com/company/darwin-discovery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…